C.M. Bidwell & Associates’s Innospec IOSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-321
Closed -$33K 538
2022
Q4
$33K Buy
+321
New +$32.6K 0.03% 320
2018
Q4
Sell
-725
Closed -$56K 424
2018
Q3
$56K Sell
725
-90
-11% -$7.01K 0.05% 225
2018
Q2
$62K Sell
815
-40
-5% -$3K 0.06% 234
2018
Q1
$59K Sell
855
-1,155
-57% -$80.3K 0.05% 234
2017
Q4
$142K Buy
+2,010
New +$134K 0.12% 187
2016
Q4
Sell
-2,410
Closed -$147K 266
2016
Q3
$147K Buy
+2,410
New +$134K 0.04% 191
2016
Q2
Sell
-1,860
Closed -$81K 283
2016
Q1
$81K Sell
1,860
-1,815
-49% -$83.9K 0.02% 219
2015
Q4
$200K Buy
3,675
+1,815
+98% +$100K 0.05% 154
2015
Q3
$87K Buy
+1,860
New +$85.3K 0.02% 202

Other funds holding IOSP

C.M. Bidwell & Associates's IOSP Position: Q1 2023 in Review

C.M. Bidwell & Associates sold out of Innospec (IOSP) in Q1 2023, closing a stake of 321 shares — an estimated $33K sold.

C.M. Bidwell & Associates first reported a position in IOSP in Q3 2015 and held it in 9 quarters. The position peaked at $200K in Q4 2015. 219 funds tracked by Wall St. Rank hold IOSP as of Q1 2023.

  • C.M. Bidwell & Associates reported no remaining Innospec position as of Q1 2023 after selling out during the quarter.
  • C.M. Bidwell & Associates sold 321 Innospec shares in Q1 2023, an estimated $33K.
  • C.M. Bidwell & Associates first reported a position in Innospec in Q3 2015 and held it in 9 quarters.
  • C.M. Bidwell & Associates's Innospec position peaked at $200K in Q4 2015.
  • 219 funds tracked by Wall St. Rank held Innospec as of Q1 2023.

Based on C.M. Bidwell & Associates's 13F filing for Q1 2023, filed 12 May 2023.